nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—TNNC1—dilated cardiomyopathy	0.703	1	CbGaD
Bepridil—KCNQ1—endocardium—dilated cardiomyopathy	0.0193	0.223	CbGeAlD
Bepridil—ABCB1—Lisinopril—dilated cardiomyopathy	0.0143	0.532	CbGbCtD
Bepridil—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0143	0.165	CbGeAlD
Bepridil—CACNA1D—sinoatrial node—dilated cardiomyopathy	0.0127	0.146	CbGeAlD
Bepridil—ABCB1—Spironolactone—dilated cardiomyopathy	0.0126	0.468	CbGbCtD
Bepridil—KCNH2—endocardium—dilated cardiomyopathy	0.00736	0.0849	CbGeAlD
Bepridil—Acute myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00407	0.106	CcSEcCtD
Bepridil—CALM1—sympathetic nervous system—dilated cardiomyopathy	0.00318	0.0367	CbGeAlD
Bepridil—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.0031	0.081	CcSEcCtD
Bepridil—TNNC1—cardiac ventricle—dilated cardiomyopathy	0.002	0.0231	CbGeAlD
Bepridil—TNNC1—myocardium—dilated cardiomyopathy	0.00188	0.0217	CbGeAlD
Bepridil—KCNQ1—myocardium—dilated cardiomyopathy	0.00153	0.0176	CbGeAlD
Bepridil—PDE1B—heart—dilated cardiomyopathy	0.00137	0.0158	CbGeAlD
Bepridil—TNNC1—heart—dilated cardiomyopathy	0.00131	0.0151	CbGeAlD
Bepridil—Gastritis—Spironolactone—dilated cardiomyopathy	0.00117	0.0306	CcSEcCtD
Bepridil—PDE1A—heart—dilated cardiomyopathy	0.00115	0.0132	CbGeAlD
Bepridil—TNNC1—cardiac atrium—dilated cardiomyopathy	0.00112	0.013	CbGeAlD
Bepridil—CACNA2D2—heart—dilated cardiomyopathy	0.0011	0.0127	CbGeAlD
Bepridil—KCNQ1—heart—dilated cardiomyopathy	0.00107	0.0123	CbGeAlD
Bepridil—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00105	0.0275	CcSEcCtD
Bepridil—CACNA1C—cardiac ventricle—dilated cardiomyopathy	0.00104	0.012	CbGeAlD
Bepridil—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00102	0.0266	CcSEcCtD
Bepridil—CACNA2D2—cardiac atrium—dilated cardiomyopathy	0.000944	0.0109	CbGeAlD
Bepridil—KCNQ1—cardiac atrium—dilated cardiomyopathy	0.000912	0.0105	CbGeAlD
Bepridil—CACNA1H—heart—dilated cardiomyopathy	0.000895	0.0103	CbGeAlD
Bepridil—CALM3—cardiac ventricle—dilated cardiomyopathy	0.00087	0.01	CbGeAlD
Bepridil—CALM3—myocardium—dilated cardiomyopathy	0.000819	0.00945	CbGeAlD
Bepridil—ATP1A1—cardiac ventricle—dilated cardiomyopathy	0.000776	0.00896	CbGeAlD
Bepridil—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000744	0.0194	CcSEcCtD
Bepridil—ATP1A1—myocardium—dilated cardiomyopathy	0.00073	0.00843	CbGeAlD
Bepridil—CALM2—cardiac ventricle—dilated cardiomyopathy	0.000684	0.00789	CbGeAlD
Bepridil—CACNA1C—heart—dilated cardiomyopathy	0.000682	0.00788	CbGeAlD
Bepridil—CALM1—cardiac ventricle—dilated cardiomyopathy	0.00068	0.00785	CbGeAlD
Bepridil—CALM2—myocardium—dilated cardiomyopathy	0.000643	0.00742	CbGeAlD
Bepridil—CALM1—myocardium—dilated cardiomyopathy	0.00064	0.00739	CbGeAlD
Bepridil—CACNA1D—cardiac atrium—dilated cardiomyopathy	0.000632	0.0073	CbGeAlD
Bepridil—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.000619	0.00715	CbGeAlD
Bepridil—CACNA1C—cardiac atrium—dilated cardiomyopathy	0.000584	0.00674	CbGeAlD
Bepridil—KCNH2—myocardium—dilated cardiomyopathy	0.000582	0.00672	CbGeAlD
Bepridil—Somnolence—Spironolactone—dilated cardiomyopathy	0.000578	0.0151	CcSEcCtD
Bepridil—CALM3—heart—dilated cardiomyopathy	0.000571	0.0066	CbGeAlD
Bepridil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000561	0.0147	CcSEcCtD
Bepridil—Arthritis—Lisinopril—dilated cardiomyopathy	0.000556	0.0145	CcSEcCtD
Bepridil—Drowsiness—Furosemide—dilated cardiomyopathy	0.000555	0.0145	CcSEcCtD
Bepridil—Sweating—Furosemide—dilated cardiomyopathy	0.000532	0.0139	CcSEcCtD
Bepridil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000514	0.0134	CcSEcCtD
Bepridil—ATP1A1—heart—dilated cardiomyopathy	0.00051	0.00588	CbGeAlD
Bepridil—CALM3—cardiac atrium—dilated cardiomyopathy	0.000489	0.00564	CbGeAlD
Bepridil—Gastritis—Lisinopril—dilated cardiomyopathy	0.000478	0.0125	CcSEcCtD
Bepridil—Influenza—Lisinopril—dilated cardiomyopathy	0.000467	0.0122	CcSEcCtD
Bepridil—Tinnitus—Furosemide—dilated cardiomyopathy	0.000464	0.0121	CcSEcCtD
Bepridil—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000455	0.0119	CcSEcCtD
Bepridil—CALM2—heart—dilated cardiomyopathy	0.000449	0.00518	CbGeAlD
Bepridil—CALM1—heart—dilated cardiomyopathy	0.000447	0.00516	CbGeAlD
Bepridil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000445	0.0116	CcSEcCtD
Bepridil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000445	0.0116	CcSEcCtD
Bepridil—ATP1A1—cardiac atrium—dilated cardiomyopathy	0.000436	0.00503	CbGeAlD
Bepridil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00043	0.0112	CcSEcCtD
Bepridil—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00043	0.0112	CcSEcCtD
Bepridil—Flatulence—Furosemide—dilated cardiomyopathy	0.000427	0.0112	CcSEcCtD
Bepridil—Depression—Lisinopril—dilated cardiomyopathy	0.000415	0.0108	CcSEcCtD
Bepridil—Rash—Spironolactone—dilated cardiomyopathy	0.00041	0.0107	CcSEcCtD
Bepridil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00041	0.0107	CcSEcCtD
Bepridil—Vision blurred—Furosemide—dilated cardiomyopathy	0.000409	0.0107	CcSEcCtD
Bepridil—Headache—Spironolactone—dilated cardiomyopathy	0.000407	0.0106	CcSEcCtD
Bepridil—KCNH2—heart—dilated cardiomyopathy	0.000407	0.00469	CbGeAlD
Bepridil—Sweating—Lisinopril—dilated cardiomyopathy	0.000399	0.0104	CcSEcCtD
Bepridil—Vertigo—Furosemide—dilated cardiomyopathy	0.000389	0.0102	CcSEcCtD
Bepridil—Nausea—Spironolactone—dilated cardiomyopathy	0.000386	0.0101	CcSEcCtD
Bepridil—CALM2—cardiac atrium—dilated cardiomyopathy	0.000384	0.00443	CbGeAlD
Bepridil—CALM1—cardiac atrium—dilated cardiomyopathy	0.000382	0.00441	CbGeAlD
Bepridil—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00038	0.00994	CcSEcCtD
Bepridil—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000375	0.00979	CcSEcCtD
Bepridil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000371	0.00969	CcSEcCtD
Bepridil—Dry mouth—Furosemide—dilated cardiomyopathy	0.000361	0.00943	CcSEcCtD
Bepridil—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000348	0.0091	CcSEcCtD
Bepridil—Shock—Furosemide—dilated cardiomyopathy	0.000348	0.00909	CcSEcCtD
Bepridil—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000348	0.00401	CbGeAlD
Bepridil—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000342	0.00893	CcSEcCtD
Bepridil—Anorexia—Furosemide—dilated cardiomyopathy	0.000337	0.00881	CcSEcCtD
Bepridil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000334	0.00872	CcSEcCtD
Bepridil—Flatulence—Lisinopril—dilated cardiomyopathy	0.00032	0.00837	CcSEcCtD
Bepridil—Tension—Lisinopril—dilated cardiomyopathy	0.000319	0.00834	CcSEcCtD
Bepridil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000318	0.0083	CcSEcCtD
Bepridil—Nervousness—Lisinopril—dilated cardiomyopathy	0.000316	0.00825	CcSEcCtD
Bepridil—Somnolence—Furosemide—dilated cardiomyopathy	0.000315	0.00822	CcSEcCtD
Bepridil—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000308	0.00803	CcSEcCtD
Bepridil—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000307	0.00801	CcSEcCtD
Bepridil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000305	0.00798	CcSEcCtD
Bepridil—Tremor—Lisinopril—dilated cardiomyopathy	0.000305	0.00796	CcSEcCtD
Bepridil—Constipation—Furosemide—dilated cardiomyopathy	0.000303	0.0079	CcSEcCtD
Bepridil—Pain—Furosemide—dilated cardiomyopathy	0.000303	0.0079	CcSEcCtD
Bepridil—Vertigo—Lisinopril—dilated cardiomyopathy	0.000292	0.00763	CcSEcCtD
Bepridil—Syncope—Lisinopril—dilated cardiomyopathy	0.000292	0.00762	CcSEcCtD
Bepridil—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000289	0.00756	CcSEcCtD
Bepridil—Palpitations—Lisinopril—dilated cardiomyopathy	0.000287	0.00751	CcSEcCtD
Bepridil—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000286	0.00747	CcSEcCtD
Bepridil—Cough—Lisinopril—dilated cardiomyopathy	0.000284	0.00741	CcSEcCtD
Bepridil—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00028	0.00731	CcSEcCtD
Bepridil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00028	0.00731	CcSEcCtD
Bepridil—Myalgia—Lisinopril—dilated cardiomyopathy	0.000277	0.00723	CcSEcCtD
Bepridil—Anxiety—Lisinopril—dilated cardiomyopathy	0.000276	0.00721	CcSEcCtD
Bepridil—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000271	0.00707	CcSEcCtD
Bepridil—Oedema—Lisinopril—dilated cardiomyopathy	0.000265	0.00693	CcSEcCtD
Bepridil—Shock—Lisinopril—dilated cardiomyopathy	0.000261	0.00682	CcSEcCtD
Bepridil—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000257	0.0067	CcSEcCtD
Bepridil—Asthenia—Furosemide—dilated cardiomyopathy	0.000254	0.00663	CcSEcCtD
Bepridil—Anorexia—Lisinopril—dilated cardiomyopathy	0.000253	0.00661	CcSEcCtD
Bepridil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000242	0.00632	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000242	0.00632	CcSEcCtD
Bepridil—Insomnia—Lisinopril—dilated cardiomyopathy	0.00024	0.00627	CcSEcCtD
Bepridil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000238	0.00623	CcSEcCtD
Bepridil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000237	0.00618	CcSEcCtD
Bepridil—Somnolence—Lisinopril—dilated cardiomyopathy	0.000236	0.00616	CcSEcCtD
Bepridil—Dizziness—Furosemide—dilated cardiomyopathy	0.000234	0.00611	CcSEcCtD
Bepridil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000234	0.0061	CcSEcCtD
Bepridil—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000231	0.00603	CcSEcCtD
Bepridil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000229	0.00599	CcSEcCtD
Bepridil—Pain—Lisinopril—dilated cardiomyopathy	0.000227	0.00593	CcSEcCtD
Bepridil—Constipation—Lisinopril—dilated cardiomyopathy	0.000227	0.00593	CcSEcCtD
Bepridil—Rash—Furosemide—dilated cardiomyopathy	0.000223	0.00583	CcSEcCtD
Bepridil—Dermatitis—Furosemide—dilated cardiomyopathy	0.000223	0.00582	CcSEcCtD
Bepridil—Headache—Furosemide—dilated cardiomyopathy	0.000222	0.00579	CcSEcCtD
Bepridil—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000217	0.00567	CcSEcCtD
Bepridil—Nausea—Furosemide—dilated cardiomyopathy	0.00021	0.00549	CcSEcCtD
Bepridil—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00021	0.00548	CcSEcCtD
Bepridil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00021	0.00548	CcSEcCtD
Bepridil—Asthenia—Lisinopril—dilated cardiomyopathy	0.00019	0.00498	CcSEcCtD
Bepridil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000182	0.00474	CcSEcCtD
Bepridil—ABCB1—heart—dilated cardiomyopathy	0.000178	0.00206	CbGeAlD
Bepridil—Dizziness—Lisinopril—dilated cardiomyopathy	0.000176	0.00459	CcSEcCtD
Bepridil—Rash—Lisinopril—dilated cardiomyopathy	0.000167	0.00437	CcSEcCtD
Bepridil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000167	0.00437	CcSEcCtD
Bepridil—Headache—Lisinopril—dilated cardiomyopathy	0.000166	0.00434	CcSEcCtD
Bepridil—Nausea—Lisinopril—dilated cardiomyopathy	0.000158	0.00412	CcSEcCtD
Bepridil—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.000152	0.591	CrCbGaD
Bepridil—Phenoxybenzamine—ADRB2—dilated cardiomyopathy	0.000105	0.409	CrCbGaD
Bepridil—PDE1B—Immune System—RAC1—dilated cardiomyopathy	1.4e-05	9.69e-05	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	1.4e-05	9.65e-05	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	1.4e-05	9.65e-05	CbGpPWpGaD
Bepridil—CALM3—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.36e-05	9.43e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.36e-05	9.41e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.35e-05	9.3e-05	CbGpPWpGaD
Bepridil—CALM2—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.32e-05	9.12e-05	CbGpPWpGaD
Bepridil—CALM1—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.32e-05	9.12e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—ITGB1—dilated cardiomyopathy	1.32e-05	9.12e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.31e-05	9.03e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—RAC1—dilated cardiomyopathy	1.29e-05	8.95e-05	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	1.28e-05	8.86e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.28e-05	8.83e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—ITGB1—dilated cardiomyopathy	1.28e-05	8.82e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—ITGB1—dilated cardiomyopathy	1.28e-05	8.82e-05	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—EGFR—dilated cardiomyopathy	1.27e-05	8.77e-05	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	1.24e-05	8.57e-05	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	1.24e-05	8.57e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.23e-05	8.51e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.23e-05	8.51e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—GPX1—dilated cardiomyopathy	1.21e-05	8.36e-05	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—TNF—dilated cardiomyopathy	1.21e-05	8.35e-05	CbGpPWpGaD
Bepridil—CALM3—Downstream signal transduction—EGFR—dilated cardiomyopathy	1.2e-05	8.33e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR—EGFR—dilated cardiomyopathy	1.2e-05	8.29e-05	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—EGFR—dilated cardiomyopathy	1.2e-05	8.27e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by ERBB2—EGFR—dilated cardiomyopathy	1.19e-05	8.25e-05	CbGpPWpGaD
Bepridil—CALM3—DAP12 signaling—EGFR—dilated cardiomyopathy	1.19e-05	8.21e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—CD36—dilated cardiomyopathy	1.18e-05	8.14e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.17e-05	8.07e-05	CbGpPWpGaD
Bepridil—CALM2—Downstream signal transduction—EGFR—dilated cardiomyopathy	1.17e-05	8.06e-05	CbGpPWpGaD
Bepridil—CALM1—Downstream signal transduction—EGFR—dilated cardiomyopathy	1.17e-05	8.06e-05	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.16e-05	8.03e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR—EGFR—dilated cardiomyopathy	1.16e-05	8.02e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—EGFR—dilated cardiomyopathy	1.16e-05	8.02e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—EGFR—dilated cardiomyopathy	1.15e-05	7.98e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by ERBB2—EGFR—dilated cardiomyopathy	1.15e-05	7.98e-05	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—EGFR—dilated cardiomyopathy	1.15e-05	7.94e-05	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—EGFR—dilated cardiomyopathy	1.15e-05	7.94e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—ITGB1—dilated cardiomyopathy	1.14e-05	7.88e-05	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—RAF1—dilated cardiomyopathy	1.13e-05	7.82e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—CD36—dilated cardiomyopathy	1.12e-05	7.78e-05	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	1.12e-05	7.72e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	1.12e-05	7.72e-05	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—EGFR—dilated cardiomyopathy	1.12e-05	7.72e-05	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—EGFR—dilated cardiomyopathy	1.11e-05	7.71e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.11e-05	7.69e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—RAF1—dilated cardiomyopathy	1.11e-05	7.67e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—EGFR—dilated cardiomyopathy	1.11e-05	7.65e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—ITGB1—dilated cardiomyopathy	1.1e-05	7.62e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—ITGB1—dilated cardiomyopathy	1.1e-05	7.62e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	1.1e-05	7.58e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.1e-05	7.58e-05	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—RAF1—dilated cardiomyopathy	1.09e-05	7.57e-05	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—RAF1—dilated cardiomyopathy	1.09e-05	7.57e-05	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—EGFR—dilated cardiomyopathy	1.09e-05	7.57e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—EGFR—dilated cardiomyopathy	1.09e-05	7.55e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—CD36—dilated cardiomyopathy	1.09e-05	7.52e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—CD36—dilated cardiomyopathy	1.09e-05	7.52e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	1.08e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—EGFR—dilated cardiomyopathy	1.08e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	1.08e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—EGFR—dilated cardiomyopathy	1.08e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	1.08e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	1.08e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.07e-05	7.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.07e-05	7.43e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—RAF1—dilated cardiomyopathy	1.07e-05	7.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—RAF1—dilated cardiomyopathy	1.07e-05	7.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—EGFR—dilated cardiomyopathy	1.07e-05	7.4e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—EGFR—dilated cardiomyopathy	1.07e-05	7.4e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—GPX1—dilated cardiomyopathy	1.06e-05	7.35e-05	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—TNF—dilated cardiomyopathy	1.06e-05	7.34e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	1.06e-05	7.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	1.06e-05	7.34e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AGT—dilated cardiomyopathy	1.06e-05	7.33e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—RAC1—dilated cardiomyopathy	1.06e-05	7.33e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—EGFR—dilated cardiomyopathy	1.06e-05	7.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—EGFR—dilated cardiomyopathy	1.06e-05	7.3e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NPPA—dilated cardiomyopathy	1.05e-05	7.28e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.04e-05	7.18e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.04e-05	7.18e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.04e-05	7.18e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.04e-05	7.18e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	7.15e-05	CbGpPWpGaD
Bepridil—CALM3—B Cell Activation—EGFR—dilated cardiomyopathy	1.03e-05	7.15e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—RAC1—dilated cardiomyopathy	1.03e-05	7.09e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—RAC1—dilated cardiomyopathy	1.03e-05	7.09e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PSEN2—dilated cardiomyopathy	1.02e-05	7.06e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NPPA—dilated cardiomyopathy	1.02e-05	7.05e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NPPA—dilated cardiomyopathy	1.02e-05	7.05e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.02e-05	7.03e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—RAF1—dilated cardiomyopathy	1.02e-05	7.03e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CD36—dilated cardiomyopathy	1.01e-05	7e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1e-05	6.94e-05	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—EGFR—dilated cardiomyopathy	1e-05	6.91e-05	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—EGFR—dilated cardiomyopathy	1e-05	6.91e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.98e-06	6.9e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.91e-06	6.85e-05	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	9.89e-06	6.84e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PSEN2—dilated cardiomyopathy	9.87e-06	6.82e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PSEN2—dilated cardiomyopathy	9.87e-06	6.82e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CD36—dilated cardiomyopathy	9.79e-06	6.77e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CD36—dilated cardiomyopathy	9.79e-06	6.77e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD36—dilated cardiomyopathy	9.72e-06	6.72e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.67e-06	6.69e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.66e-06	6.68e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.66e-06	6.68e-05	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	9.57e-06	6.62e-05	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	9.57e-06	6.62e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—RAC1—dilated cardiomyopathy	9.54e-06	6.6e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.47e-06	6.55e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD36—dilated cardiomyopathy	9.4e-06	6.5e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD36—dilated cardiomyopathy	9.4e-06	6.5e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—RAF1—dilated cardiomyopathy	9.38e-06	6.49e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.35e-06	6.47e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.35e-06	6.47e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AGT—dilated cardiomyopathy	9.31e-06	6.44e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—RAF1—dilated cardiomyopathy	9.29e-06	6.43e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—RAC1—dilated cardiomyopathy	9.23e-06	6.38e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—RAC1—dilated cardiomyopathy	9.23e-06	6.38e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—RAC1—dilated cardiomyopathy	9.16e-06	6.34e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—RAC1—dilated cardiomyopathy	9.06e-06	6.27e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—RAC1—dilated cardiomyopathy	8.86e-06	6.13e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—RAC1—dilated cardiomyopathy	8.86e-06	6.13e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AGT—dilated cardiomyopathy	8.66e-06	5.99e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—RAF1—dilated cardiomyopathy	8.58e-06	5.93e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.26e-06	5.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.99e-06	5.52e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.99e-06	5.52e-05	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.96e-06	5.51e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.83e-06	5.42e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.63e-06	5.27e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—EGFR—dilated cardiomyopathy	7.61e-06	5.26e-05	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.58e-06	5.24e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.58e-06	5.24e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.58e-06	5.24e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—EGFR—dilated cardiomyopathy	7.36e-06	5.09e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—EGFR—dilated cardiomyopathy	7.36e-06	5.09e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.14e-06	4.94e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—RAF1—dilated cardiomyopathy	7.03e-06	4.86e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.98e-06	4.82e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EGFR—dilated cardiomyopathy	6.97e-06	4.82e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—ITGB1—dilated cardiomyopathy	6.91e-06	4.78e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.91e-06	4.78e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.91e-06	4.78e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—RAF1—dilated cardiomyopathy	6.8e-06	4.7e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—RAF1—dilated cardiomyopathy	6.8e-06	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ITGB1—dilated cardiomyopathy	6.69e-06	4.62e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ITGB1—dilated cardiomyopathy	6.69e-06	4.62e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.57e-06	4.54e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—EGFR—dilated cardiomyopathy	6.43e-06	4.45e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EGFR—dilated cardiomyopathy	6.37e-06	4.41e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.34e-06	4.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.34e-06	4.39e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—RAF1—dilated cardiomyopathy	6.33e-06	4.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.14e-06	4.24e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.14e-06	4.24e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.14e-06	4.24e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.14e-06	4.24e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—RAF1—dilated cardiomyopathy	6.12e-06	4.23e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—RAF1—dilated cardiomyopathy	6.12e-06	4.23e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.08e-06	4.21e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—RAF1—dilated cardiomyopathy	6.07e-06	4.2e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.01e-06	4.15e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.9e-06	4.08e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD36—dilated cardiomyopathy	5.9e-06	4.08e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—EGFR—dilated cardiomyopathy	5.88e-06	4.07e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.88e-06	4.07e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.88e-06	4.07e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—RAF1—dilated cardiomyopathy	5.88e-06	4.06e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—RAF1—dilated cardiomyopathy	5.88e-06	4.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AGT—dilated cardiomyopathy	5.81e-06	4.02e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.71e-06	3.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.71e-06	3.95e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.71e-06	3.95e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD36—dilated cardiomyopathy	5.7e-06	3.94e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD36—dilated cardiomyopathy	5.7e-06	3.94e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.62e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AGT—dilated cardiomyopathy	5.62e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—RAC1—dilated cardiomyopathy	5.56e-06	3.84e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.53e-06	3.82e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.53e-06	3.82e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—RAC1—dilated cardiomyopathy	5.38e-06	3.72e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—RAC1—dilated cardiomyopathy	5.38e-06	3.72e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—RAC1—dilated cardiomyopathy	5.13e-06	3.55e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—RAC1—dilated cardiomyopathy	4.96e-06	3.43e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—RAC1—dilated cardiomyopathy	4.96e-06	3.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.88e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.72e-06	3.26e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.72e-06	3.26e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GPX1—dilated cardiomyopathy	4.68e-06	3.24e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.63e-06	3.2e-05	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.61e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CD36—dilated cardiomyopathy	4.56e-06	3.15e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GPX1—dilated cardiomyopathy	4.53e-06	3.13e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GPX1—dilated cardiomyopathy	4.53e-06	3.13e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.51e-06	3.12e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.48e-06	3.1e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.48e-06	3.1e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CD36—dilated cardiomyopathy	4.41e-06	3.05e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CD36—dilated cardiomyopathy	4.41e-06	3.05e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—dilated cardiomyopathy	4.34e-06	3e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—dilated cardiomyopathy	4.2e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—dilated cardiomyopathy	4.2e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—dilated cardiomyopathy	4.17e-06	2.88e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.12e-06	2.85e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AGT—dilated cardiomyopathy	4.11e-06	2.84e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.03e-06	2.79e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—dilated cardiomyopathy	4.03e-06	2.79e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—dilated cardiomyopathy	4.03e-06	2.79e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.98e-06	2.75e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AGT—dilated cardiomyopathy	3.97e-06	2.75e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AGT—dilated cardiomyopathy	3.97e-06	2.75e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.9e-06	2.7e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.9e-06	2.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.85e-06	2.66e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.85e-06	2.66e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—RAF1—dilated cardiomyopathy	3.68e-06	2.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.59e-06	2.48e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—RAF1—dilated cardiomyopathy	3.56e-06	2.46e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—RAF1—dilated cardiomyopathy	3.56e-06	2.46e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.55e-06	2.45e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.48e-06	2.4e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.48e-06	2.4e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.46e-06	2.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AGT—dilated cardiomyopathy	3.43e-06	2.37e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—RAF1—dilated cardiomyopathy	3.4e-06	2.35e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.34e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.32e-06	2.3e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AGT—dilated cardiomyopathy	3.32e-06	2.3e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—RAF1—dilated cardiomyopathy	3.29e-06	2.28e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—RAF1—dilated cardiomyopathy	3.29e-06	2.28e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.26e-06	2.25e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.11e-06	2.15e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.93e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.77e-06	1.91e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.68e-06	1.85e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.68e-06	1.85e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—dilated cardiomyopathy	2.53e-06	1.75e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—dilated cardiomyopathy	2.44e-06	1.69e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—dilated cardiomyopathy	2.44e-06	1.69e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.38e-06	1.65e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—dilated cardiomyopathy	2.33e-06	1.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.3e-06	1.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.3e-06	1.59e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—dilated cardiomyopathy	2.26e-06	1.56e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—dilated cardiomyopathy	2.26e-06	1.56e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.63e-06	1.13e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.58e-06	1.09e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.58e-06	1.09e-05	CbGpPWpGaD
